CAPTRUST Financial Advisors’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,799
Closed -$128K 3280
2026
Q1
$128K Buy
+10,799
New +$111K ﹤0.01% 2773
2024
Q2
Sell
-14,938
Closed -$172K 2198
2024
Q1
$172K Sell
14,938
-9,662
-39% -$82.1K ﹤0.01% 2011
2023
Q4
$179K Sell
24,600
-4,162
-14% -$32.8K ﹤0.01% 2425
2023
Q3
$262K Buy
28,762
+13,396
+87% +$161K ﹤0.01% 2090
2023
Q2
$187K Buy
+15,366
New +$171K ﹤0.01% 2278
2022
Q3
Sell
-100
Closed -$2K 2108
2022
Q2
$2K Hold
100
﹤0.01% 4418
2022
Q1
$2K Sell
100
-56
-36% -$1.01K ﹤0.01% 4452
2021
Q4
$4K Sell
156
-12
-7% -$282 ﹤0.01% 4154
2021
Q3
$4K Sell
168
-282
-63% -$6.82K ﹤0.01% 4006
2021
Q2
$12K Buy
450
+78
+21% +$2.22K ﹤0.01% 3420
2021
Q1
$14K Sell
372
-28
-7% -$989 ﹤0.01% 3220
2020
Q4
$15K Buy
+400
New +$12.4K ﹤0.01% 2381

Other funds holding AHCO

CAPTRUST Financial Advisors's AHCO Position: Q2 2026 in Review

CAPTRUST Financial Advisors sold out of AdaptHealth (AHCO) in Q2 2026, closing a stake of 10,799 shares — an estimated $128K sold.

CAPTRUST Financial Advisors first reported a position in AHCO in Q4 2020 and held it in 12 quarters. The position peaked at $262K in Q3 2023. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • CAPTRUST Financial Advisors reported no remaining AdaptHealth position as of Q2 2026 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 10,799 AdaptHealth shares in Q2 2026, an estimated $128K.
  • CAPTRUST Financial Advisors first reported a position in AdaptHealth in Q4 2020 and held it in 12 quarters.
  • CAPTRUST Financial Advisors's AdaptHealth position peaked at $262K in Q3 2023.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.